Introduction/Overview
Norcantharidin (NCTD) is an important natural product derivative, whose chemical structure is derived from the active ingredient Cantharidin (CTD) in the traditional Chinese medicine Mylabris spp. As a demethylated derivative of CTD, NCTD not only retains its significant biological activity, especially its anti-tumor effect, but also exhibits superior characteristics in terms of toxicity and safety. In recent years, with the increasing demand for new small molecule drugs in the field of cancer treatment, NCTD has become a hot topic in natural product pharmacology research due to its unique anti-cancer mechanism and good drug properties. This article provides a systematic review of the chemical structure and physicochemical properties, plant sources and extraction methods, pharmacological activity and mechanism of action, pharmacological evaluation and pharmacokinetic characteristics of norcantharidin, and prospects its clinical application potential.
Chemical structure and physicochemical properties
The chemical name of norcantharidin is (Rac) -3,6-methylenedioxycyclohexane-1,2-dianhydride, with a molecular formula of C8H7O4 and a molecular weight of 168.1480. Its structure is a six membered ring containing two anhydride groups, which removes the methyl group from the molecule of cantharidin and forms a demethylated derivative. The racemic form of NCTD (Rac NCTD) is widely used in research and drug development.
In terms of physical and chemical properties, the LogP value of NCTD is -0.0359, indicating strong hydrophilicity and a water solubility of 8.0906 mg/mL. It has good water solubility, which is conducive to the improvement of bioavailability. Its topological polar surface area (TPSA) is 52.6 Å ², indicating that the molecule has moderate polarity, which is conducive to membrane penetration. The high permeability of the blood-brain barrier indicates that NCTD may have potential effects on the central nervous system. The hERG channel inhibition experiment was negative, indicating a low risk of cardiac toxicity. The Ames mutagenicity test score of 1.5 indicates that the genetic toxicity risk of NCTD is low and meets the requirements for safe drug use.
Plant sources and extraction methods
The precursor of norcantharidin, cantharidin, is mainly found in insects of the cantharidin genus, especially in species such as Mylabris phalerata and Mylabris cichorii. Traditional Chinese medicine has been widely used in the treatment of diseases such as tumors and ulcers. Due to the high toxicity of cantharidin, its direct application is limited. Norcantharidin, as a derivative, is obtained through chemical demethylation reaction.
The extraction method mainly includes the following steps:
- Raw material collection and pretreatment Collect dry bufotalin bodies and grind them into fine powder for later use.
- Organic solvent extraction Using methanol or ethanol for reflux extraction of cantharidin powder, cantharidin and its related components were extracted.
- Chemical conversion Convert cantharidin to norcantharidin through demethylation reaction under alkaline conditions. This step usually uses sodium hydroxide or potassium hydroxide as a catalyst.
- Purification and Separation Purification of norcantharidin using column chromatography, recrystallization and other techniques to obtain high-purity compounds.
- Structural Identification Modern analytical techniques such as nuclear magnetic resonance (NMR) and mass spectrometry (MS) were used to confirm the structure of the compound.
In addition, in recent years, with the development of biosynthetic technology, some studies have attempted to synthesize NCTD through microbial fermentation or biocatalytic methods in order to achieve green and efficient production processes.
Pharmacological activity research
Norcantharidin, as a multi-target anti-tumor drug, has shown significant anti-cancer activity in various tumor cell lines and animal models. Its pharmacological effects cover multiple aspects such as cell proliferation inhibition, induction of apoptosis, inhibition of tumor invasion and metastasis, and anti angiogenesis.
-
Antitumor activity
NCTD has broad-spectrum inhibitory effects on a variety of solid tumors and blood tumor cells, including liver cancer, lung cancer, breast cancer, colorectal cancer, stomach cancer, leukemia, etc. Cell experiments have shown that NCTD can significantly inhibit tumor cell proliferation, induce cell cycle arrest, and promote cell apoptosis. Animal experiments further confirmed its anti-tumor effect in vivo, and the toxic side effects were significantly reduced compared to bufotalin.
-
Inducing cell apoptosis
NCTD activates endogenous and exogenous apoptotic pathways, regulates BCL2 family protein expression, promotes mitochondrial membrane potential loss, activates caspases, and ultimately triggers programmed cell death.
-
Inhibit tumor invasion and metastasis
NCTD can downregulate the expression of matrix metalloproteinases (MMPs) such as MMP2, reduce the migration and invasion ability of tumor cells, and inhibit the process of tumor metastasis.
-
Anti angiogenic effect
By inhibiting vascular endothelial growth factor (VEGF) and its signaling pathway, NCTD blocks the formation of tumor neovascularization and limits the nutritional supply to the tumor.
-
Immune regulatory effect
Some studies have shown that NCTD can regulate immune cell activity in the tumor microenvironment and enhance the body's anti-tumor immune response.
Mechanism of action and molecular targets
The anti-tumor mechanism of norcantharidin is complex and diverse, involving multiple signaling pathways and molecular targets. The current research mainly focuses on the following key targets:
-
MCL1 and BCL2
As anti apoptotic proteins, MCL1 and BCL2 play a crucial role in tumor cell survival. NCTD can downregulate the expression of these two proteins, relieve the inhibition of apoptosis, and promote cell death.
-
STAT3 signaling pathway
Signal transducer and activator of transcription factor 3 (STAT3) is abnormally activated in various tumors, promoting cell proliferation and anti apoptosis. NCTD inhibits the phosphorylation of STAT3, blocks its nuclear translocation, and suppresses the expression of downstream oncogenes.
-
MMP2
As an important enzyme in the degradation of tumor cell matrix, inhibition of MMP2 helps to reduce the invasion and metastasis of tumor cells. NCTD significantly reduces the activity and expression level of MMP2.
-
TOP1 and TOP2A
Topoisomerase I (TOP1) and Topoisomerase II alpha (TOP2A) are key enzymes involved in DNA replication and transcription. NCTD can inhibit the activity of these two enzymes, block DNA metabolism and proliferation of tumor cells.
-
HIF1A
Hypoxia inducible factor 1 alpha (HIF1A) promotes angiogenesis and metabolic reprogramming in tumor hypoxic environments. NCTD interferes with the tumor's ability to adapt to hypoxia by inhibiting the expression of HIF1A.
-
MAPK1
Mitogen activated protein kinase 1 (MAPK1) is involved in cell proliferation and differentiation signaling. NCTD regulates the MAPK1 signaling pathway and inhibits the growth of tumor cells.
-
ESR1 and CYP19A1
Estrogen receptor alpha (ESR1) and aromatase (CYP19A1) play important roles in hormone dependent tumors (such as breast cancer). NCTD affects the hormone response of tumor cells by regulating these two targets.
Overall, NCTD achieves effective inhibition of tumor cells through multi-target and multi pathway synergistic effects, reflecting its unique advantages as a natural anti-cancer drug.
Evaluation of drug properties and pharmacokinetics
Norcantharidin exhibits good characteristics in terms of medicinal properties:
- Molecular weight and polarity The molecular weight of 168.1480 is within the ideal range for small molecule drugs, and the TPSA value is moderate, which is beneficial for cell membrane penetration and oral absorption.
- Water solubility High water solubility (8.0906 mg/mL) is helpful for formulation development and in vivo distribution.
- fat-soluble LogP is close to zero, indicating a balance between hydrophilicity and hydrophobicity, which is beneficial for adapting to multiple environments in the body.
- Blood-brain barrier permeability High permeability suggests that it may be used for the treatment of central nervous system tumors, but potential central neurotoxicity should also be considered.
- Cardiac safety The hERG channel inhibition experiment was negative, reducing the risk of arrhythmia.
- Genotoxicity The Ames test results showed low mutagenicity and high safety.
Pharmacokinetic studies have shown that NCTD is well absorbed orally, with a moderate plasma half-life, mainly metabolized through the liver, and excreted primarily through urine. Its bioavailability is greatly affected by the dosage form and administration method, and further optimization of the formulation is needed to improve in vivo stability and targeting.
Clinical application prospects and prospects
Norcantharidin, as a natural derivative with broad-spectrum anti-tumor activity, has undergone preclinical and clinical research in China and some countries. Its low toxicity and high efficiency make it show good application potential in the adjuvant treatment of various malignant tumors, such as liver cancer, lung cancer, breast cancer, etc.
The key areas for future clinical applications include:
-
Single drug and combination therapy strategies
Combining chemotherapy, radiotherapy, and targeted drugs to achieve synergistic effects and reduce the occurrence of drug resistance.
-
Development of Targeted Delivery System
By using novel drug delivery systems such as nanocarriers and liposomes, the enrichment of NCTD at the tumor site can be improved, reducing systemic toxicity and side effects.
-
Treatment of central nervous system tumors
Exploring the possibility of treating brain tumors and brain metastases by utilizing its excellent blood-brain barrier permeability.
-
Research on the immunomodulatory effect
In depth exploration of the regulation of tumor immune microenvironment by NCTD, providing theoretical basis for immune combination therapy.
-
Safety and pharmacokinetic optimization
By modifying the structure and innovating the dosage form, the stability and efficacy of drugs can be improved, and potential toxicity can be reduced.
Overall, as a natural product drug with multiple targets and mechanisms, norcantharidin has broad clinical application prospects and deserves further in-depth research and development.
Conclusion
Norcantharidin, as a demethylated derivative of cantharidin, exhibits significant anti-tumor activity and good safety due to its unique chemical structure and excellent physicochemical properties. Its multi-target and multi mechanism mode of action provides new ideas and strategies for tumor treatment. Combining the development of modern medicinal chemistry, pharmacology, and formulation, norcantharidin is expected to become an important member in the field of natural product anticancer drugs. In the future, with the deepening of clinical research and the application of new technologies, the clinical value of NCTD will be further validated and enhanced, bringing more benefits to cancer patients.
